|
TRIM37 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.83969999999678E-05 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
9.056800E-03 |
| Normal-vs-Stage2 |
1.346430E-01 |
| Normal-vs-Stage3 |
1.977660E-02 |
| Normal-vs-Stage4 |
1.685620E-01 |
| Stage1-vs-Stage2 |
9.231800E-01 |
| Stage1-vs-Stage3 |
2.650600E-01 |
| Stage1-vs-Stage4 |
3.875800E-01 |
| Stage2-vs-Stage3 |
4.715200E-01 |
| Stage2-vs-Stage4 |
4.310200E-01 |
| Stage3-vs-Stage4 |
6.125000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.969770E-04 |
| Normal-vs-AfricanAmerican |
2.764100E-02 |
| Normal-vs-Asian |
2.326600E-01 |
| Caucasian-vs-AfricanAmerican |
6.453200E-01 |
| Caucasian-vs-Asian |
6.481000E-01 |
| AfricanAmerican-vs-Asian |
5.102200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.984400E-03 |
| Normal-vs-Female |
4.96940000038748E-07 |
| Male-vs-Female |
2.776400E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
8.535800E-02 |
| Normal-vs-Extreme_Weight |
1.049200E-01 |
| Normal-vs-Obese |
4.615600E-03 |
| Normal-vs-Extreme_Obese |
3.102800E-01 |
| Normal_Weight-vs-Extreme_Weight |
4.980800E-01 |
| Normal_Weight-vs-Obese |
8.755000E-01 |
| Normal_Weight-vs-Extreme_Obese |
8.994200E-01 |
| Extreme_Weight-vs-Obese |
2.423800E-01 |
| Extreme_Weight-vs-Extreme_Obese |
5.305800E-01 |
| Obese-vs-Extreme_Obese |
9.498000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.430780E-04 |
| Normal-vs-Age(41-60Yrs) |
4.78100000000925E-06 |
| Normal-vs-Age(61-80Yrs) |
4.471900E-02 |
| Normal-vs-Age(81-100Yrs) |
2.885200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.279610E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.248200E-04 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.168880E-04 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.429900E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.338630E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
4.895700E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.018600E-03 |
| Normal-VS-Type2 PRCC |
1.782210E-02 |
| Normal-VS-KIRP CIMP |
1.019860E-02 |
| Normal-VS-Unclassified PRCC |
1.698660E-03 |
| Type1 PRCC-VS-Type2 PRCC |
6.931200E-01 |
| Type1 PRCC-VS-KIRP CIMP |
4.241700E-03 |
| Type1 PRCC-VS-Unclassified PRCC |
7.298000E-02 |
| Type2 PRCC-VS-KIRP CIMP |
3.794200E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.699800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.425200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.537790E-01 |
| Normal-vs-N1 |
1.906430E-02 |
| Normal-vs-N2 |
2.159200E-01 |
| N0-vs-N1 |
8.128000E-02 |
| N0-vs-N2 |
3.664000E-02 |
| N1-vs-N2 |
6.239000E-01 |
|
|
